Seeking Alpha

Synergy Pharmaceuticals (SGYP +21%) ramps significantly higher today after is Q3 loss came in...

Synergy Pharmaceuticals (SGYP +21%) ramps significantly higher today after is Q3 loss came in better than Street expectations. The company didn't report any revenues during the quarter. It ended the quarter with about $37.4M in cash and equivalents on hand, up significantly from the $13.2M deficit recorded at the end of 2011.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|